is hims glp-1 fda approved The announced plans to take action against non-FDA-approved receptor agonists, a move that prompted telehealth company & Hers to yank its new compounded semaglutide (Wegovy) weight-loss pill from the Hims Launched a New Weight

In a statement, FDA wrote, FDA is also taking steps to combat misleading direct-to-consumer advertising and marketing following warning letters that were sent in the fall of 2025

Keep in mind that neither medication replaces healthy eating and physical activity

By January 23rd, weekly prescriptions had already reached approximately 50,000, with more than 170,000 patients on therapy

They should be used cautiously in people with a history of medullary thyroid cancer or MEN 2 syndrome

Dominguez, though given their price point, she can understand why people would want to give them a try

Although GI AEs are common across all GLP-1 RAs, differences in formulation, dosing, and dual agonism with tirzepatide can influence how well patients tolerate therapy